Form 4: Cytosorbents CEO Buys Shares
Insider Transaction (Form 4)
Phillip P. Chan, Chief Executive Officer and a Director of Cytosorbents Corp, purchased 3,774 shares of common stock on September 15, 2026 for $6.00 per share.
Summary
- Open-market purchase: acquired 3,774 Common Stock at $6.00 ($22,644) on September 15, 2026; holds 100,996 after (Direct).
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $22,644, committing personal capital to the stock.
Insider Transactions
Phillip P. Chan — Director, Officer (Chief Executive Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-15 | Open-market purchase | Common Stock | 3,774 | $6 | $22.6K | 100,996 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-15 | Open-market purchase (3,774 shares) |
Keywords
insider transaction, Form 4, CTSO, Cytosorbents Corp, bullish, Phillip P. Chan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.